JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266122

Human SLC25A10 (Mitochondrial dicarboxylate carrier) knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

SLC25A10 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 7 bp deletion in exon 1 and Insertion of the selection cassette in exon 1.

View Alternative Names

SLC25A10, Solute carrier family 25 member 10

2 Images
Sanger Sequencing - Human SLC25A10 (Mitochondrial dicarboxylate carrier) knockout HEK-293T cell line (AB266122)
  • Sanger seq

Unknown

Sanger Sequencing - Human SLC25A10 (Mitochondrial dicarboxylate carrier) knockout HEK-293T cell line (AB266122)

Allele-1 : 7 bp deletion in exon1

Sanger Sequencing - Human SLC25A10 (Mitochondrial dicarboxylate carrier) knockout HEK-293T cell line (AB266122)
  • Sanger seq

Unknown

Sanger Sequencing - Human SLC25A10 (Mitochondrial dicarboxylate carrier) knockout HEK-293T cell line (AB266122)

Allele-2 : Insertion of the selection cassette in exon 1.

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 7 bp deletion in exon 1 and Insertion of the selection cassette in exon 1

Product details

Recommended control: Human wild-type HEK293T cell line (ab255449). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266122-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266122 Human SLC25A10 (Mitochondrial dicarboxylate carrier) knockout HEK-293T cell line", "number":"AB266122-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266122-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266122 Human SLC25A10 (Mitochondrial dicarboxylate carrier) knockout HEK-293T cell line", "number":"AB266122-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
SLC25A10
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The mitochondrial dicarboxylate carrier also known as the dicarboxylate transporter facilitates the exchange of dicarboxylates across the mitochondrial inner membrane. This carrier protein often termed the dicarboxylate carrier or oxodicarboxylate transporter possesses a molecular mass of approximately 31 kilodaltons and is expressed predominantly in metabolically active tissues such as liver kidney and heart. Its key function lies in transporting four-carbon dicarboxylates like succinate and malate important for energy and metabolic equilibrium.
Biological function summary

The mitochondrial dicarboxylate carrier aids in mitochondrial processes by mediating the shuttle of dicarboxylates important for the tricarboxylic acid (TCA) cycle and urea cycle. It actively participates in the transfer of metabolites that contribute to the synthesis of ATP linking important metabolic routes. The dicarboxylate carrier operates as a part of the family of mitochondrial transport proteins but does not form part of a larger protein complex.

Pathways

The dicarboxylate carrier intersects several key metabolic pathways including the TCA cycle and gluconeogenesis. Through these pathways the protein collaborates with others like the adenine nucleotide translocase; it aids in maintaining energetic homeostasis within cells. The correct functioning of the dicarboxylate carrier ensures the proper flow of carbon skeletons essential for cellular respiration and energy production.

The malfunction of the mitochondrial dicarboxylate carrier links to metabolic conditions like renal tubular acidosis and certain forms of mitochondrial myopathy. The carrier's dysfunction may result in disrupted acid-base homeostasis within the kidneys due to impaired succinate transport. In these contexts proteins such as the mitochondrial pyruvate carrier may exhibit interconnected roles further influencing pathological states. Understanding the carrier's activity impacts strategies for addressing metabolic dysregulations associated with mitochondrial diseases.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com